Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 475.82M | 430.27M | 325.19M | 605.91M | 537.37M |
| Total Depreciation and Amortization | 196.95M | 193.43M | 189.12M | 182.98M | 176.09M |
| Total Amortization of Deferred Charges | 25.25M | 40.10M | 40.10M | 40.10M | 40.10M |
| Total Other Non-Cash Items | 491.98M | 558.83M | 656.21M | 330.94M | 348.95M |
| Change in Net Operating Assets | 53.64M | -24.07M | -30.08M | -104.32M | -108.11M |
| Cash from Operations | 1.24B | 1.20B | 1.18B | 1.06B | 994.40M |
| Capital Expenditure | -215.61M | -219.36M | -236.70M | -212.93M | -194.68M |
| Sale of Property, Plant, and Equipment | 1.87M | 1.88M | 1.41M | 457.30K | 717.30K |
| Cash Acquisitions | -21.77M | -21.77M | -22.08M | -- | -- |
| Divestitures | -- | 0.00 | 0.00 | 0.00 | 27.44M |
| Other Investing Activities | -33.28M | -27.34M | -27.52M | -20.16M | -20.90M |
| Cash from Investing | -268.79M | -266.60M | -284.89M | -232.63M | -187.42M |
| Total Debt Issued | 621.00M | 2.33B | 3.17B | 3.16B | 2.78B |
| Total Debt Repaid | -2.19B | -3.04B | -3.39B | -3.04B | -3.04B |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 0.00 | 28.00M |
| Repurchase of Common Stock | -- | -- | -- | -1.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -807.58M | -807.58M | -803.78M | -803.78M | -718.93M |
| Other Financing Activities | -4.06B | -3.83B | -3.83B | -3.83B | -3.83B |
| Cash from Financing | -1.05B | -921.18M | -839.83M | -777.91M | -773.65M |
| Foreign Exchange rate Adjustments | 4.84M | 3.12M | -3.46M | -8.13M | -7.26M |
| Miscellaneous Cash Flow Adjustments | 469.80K | 469.80K | 469.80K | -- | -- |
| Net Change in Cash | -67.36M | 14.37M | 52.82M | 36.94M | 26.06M |